Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Suyog M. Amrutkar"'
Autor:
Anmada Nayak, Sankar K. Guchhait, Garima Priyadarshani, Uttam Chand Banerjee, Suyog M. Amrutkar, Chanakya Nath Kundu, Sarita Das
Publikováno v:
ACS Medicinal Chemistry Letters. 7:1056-1061
Scaffold-hopping of bioactive natural product aurones has been studied for the first time. 2-Arylideneimidazo[1,2-a]pyridinones as potential topoisomerase IIα (hTopoIIα)-targeting anticancer compounds were considered. A multifunctional activator, p
Autor:
Darpan Darpan, Ashish T. Baviskar, Sandeep Singh, Harveen Kler, Uttam Chand Banerjee, Gaurav Joshi, Raj Kumar, Suyog M. Amrutkar
Publikováno v:
RSC Advances. 6:14880-14892
Based on reported pharmacophores as topoisomerase inhibitors, 2,5-dimethylthiophene/furan based N-acetyl pyrazolines were designed and envisaged as topoisomerase inhibitors. The target compounds were synthesized and tested in vitro against human topo
Autor:
Praveen Sharma, Monika Chauhan, Suyog M. Amrutkar, Raj Kumar, Harveen Kler, Sandeep Singh, Uttam Chand Banerjee, Archana Kashyap, Gaurav Joshi, Kiran D. Bhilare
Publikováno v:
RSC Advances. 6:77717-77734
Based on the quinazoline bearing EGFR inhibitors, a series of thirty four compounds having a quinoline scaffold were synthesised and evaluated in vitro for EGFR kinase inhibitory activity. A structure–activity relationship study revealed that 2,4-b
Autor:
Santosh Kumar, Sadhana Sharma, Arshad J. Ansari, Uttam Chand Banerjee, Devesh M. Sawant, Ashoke Sharon, Gaurav Joshi, Sandeep Singh, Sourav Kalra, Suyog M. Amrutkar, Umesh Prasad Yadav, Raj Kumar, Praveen Sharma, Pankaj Kumar Singh
Publikováno v:
Bioorganic Chemistry. 94:103409
In the quest to ameliorate the camptothecin (CPT) downsides, we expedite to search for stable non-CPT analogues among 11 motifs of pyrazoloquinazolines reported. E-pharmacophore drug design approach helped filtering out pyrazolo[1,5-c]quinazolines as
Publikováno v:
Tetrahedron Letters. 54:3274-3277
R)-1-(1-Naphthyl)ethanol is an essential chiral substrate for the synthesis of nonactin and dihydro-(1H)- quinoline-2-one derivatives. Stereoinversion of (S)-1-(1-naphthyl)ethanol to (R)-1-(1-naphthyl)ethanol by whole cell biocatalysis, using Candida
Autor:
Garima, Priyadarshani, Anmada, Nayak, Suyog M, Amrutkar, Sarita, Das, Sankar K, Guchhait, Chanakya N, Kundu, Uttam C, Banerjee
Publikováno v:
ACS medicinal chemistry letters. 7(12)
Scaffold-hopping of bioactive natural product aurones has been studied for the first time. 2-Arylideneimidazo[1,2
Autor:
Sourav Kalra, Gaurav Joshi, Anil K. Mantha, Gagandeep Kaur, Ravi P. Cholia, Suyog M. Amrutkar, Raj Kumar, Uttam Chand Banerjee
Publikováno v:
Archiv der Pharmazie. 351:1800023
The design and synthesis of dihydropyrazolo[1,5-c]quinazolines (1a-h) as human topoisomerase II (TopoII) catalytic inhibitors are reported. The compounds were investigated for their antiproliferative activity against the C6 rat glial cell line. Two c
Autor:
Arvind Negi, Sandeep Singh, Jimi Marin Alex, Ashish T. Baviskar, Gaurav Joshi, Uttam Chand Banerjee, Suyog M. Amrutkar, Raj Kumar
Publikováno v:
Bioorganicmedicinal chemistry. 23(17)
Microwave-accelerated synthesis and anticancer activity of novel imine/amide–imidazole conjugates derived from 5-amino-4-cyano- N 1-substituted benzyl imidazole against a panel of seven cancer cell lines are reported for the first time. Compounds A
Autor:
Sankar K. Guchhait, Neha Trivedi, Vikas Chaudhary, Chanakya Nath Kundu, Uttam Chand Banerjee, Ashish T. Baviskar, Anmada Nayak, Prasad V. Bharatam, Suyog M. Amrutkar
Publikováno v:
ACS medicinal chemistry letters. 6(4)
A study of structure-based modulation of known ligands of hTopoIIα, an important enzyme involved in DNA processes, coupled with synthesis and in vitro assays led to the establishment of a strategy of rational switch in mode of inhibition of the enzy